Business More Activists Lay Down Arms in Battles for Boardroom Control Nick J Adam Apr 23, 2023 So far in the 2023 proxy season, shareholder activists have shown more bark than bite. At companies… Read More...
Business FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer Grail Nick J Adam Apr 4, 2023 The Federal Trade Commission rejected Illumina Inc.’s $7 billion deal for cancer-test… Read More...
Business Illumina’s Deal to Buy Cancer-Test Developer Is Blocked by the EU Nick J Adam Sep 7, 2022 By Kim Mackrael and Peter LoftusUpdated Sept. 6, 2022 4:35 pm ETListen to article(2 minutes)BRUSSELS—The European Union… Read More...
Business Illumina (ILMN) Announces Preliminary Q4 Sales, Issues ’22 View Nick J Adam Jan 12, 2022 Illumina, Inc. ILMN recently announced preliminary fourth-quarter and full-year 2021 revenues along with… Read More...
Technology EU Opens Probe Into Illumina’s Decision to Close Grail Deal Despite Antitrust Concerns Kevin Colleran Aug 20, 2021 The European Union’s executive arm said it was opening a probe into Illumina Inc.’s decision to complete its… Read More...
Technology Illumina Completes Deal for Life-Sciences Firm Grail Despite FTC Antitrust Challenge Kevin Colleran Aug 19, 2021 WASHINGTON— Illumina Inc. on Wednesday said it completed its planned $7.1 billion acquisition of Grail Inc.,… Read More...